Why the study?
Although CMR holds potential to improve risk stratification beyond the TIMI risk score in STEMI, the optimal timing for CMR after STEMI remains poorly defined.
Does the timing of CMR (early, deferred, or paired) after STEMI affect its prognostic performance for predicting death and HF hospitalization?
Population
492 reperfused STEMI patients
Comparison
Early-CMR vs deferred-CMR vs paired-CMRs stratification strategies
Design
Prospective registry-based study
Follow-up
Median 8.3 years
Authors
Loading...
CMR timing after STEMI appears interchangeable for prognosis; hypothesis-generating and should not yet alter practice.
Does the timing of CMR (early, deferred, or paired) after STEMI affect its prognostic performance for predicting death and HF hospitalization?
Early, deferred, or paired CMR strategies provide equivalent prognostic value for predicting death and heart failure hospitalization in reperfused STEMI patients.
Masci et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: